BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28483153)

  • 1. Vascular Endothelial Growth Factor Prevents Endothelial-to-Mesenchymal Transition in Hypertrophy.
    Illigens BM; Casar Berazaluce A; Poutias D; Gasser R; Del Nido PJ; Friehs I
    Ann Thorac Surg; 2017 Sep; 104(3):932-939. PubMed ID: 28483153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart.
    Friehs I; Barillas R; Vasilyev NV; Roy N; McGowan FX; del Nido PJ
    Circulation; 2006 Jul; 114(1 Suppl):I290-5. PubMed ID: 16820588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
    Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
    Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury.
    Friehs I; Moran AM; Stamm C; Choi YH; Cowan DB; McGowan FX; del Nido PJ
    Ann Thorac Surg; 2004 Jun; 77(6):2004-10; discussion 2011. PubMed ID: 15172254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
    Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
    Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan Attenuates Myocardial Endothelial-To-Mesenchymal Transition in Spontaneous Hypertensive Rats via Inhibiting TGF-β/Smad Signaling.
    Wu M; Peng Z; Zu C; Ma J; Lu S; Zhong J; Zhang S
    PLoS One; 2016; 11(5):e0155730. PubMed ID: 27176484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition.
    Zhang GH; Yu FC; Li Y; Wei Q; Song SS; Zhou FP; Tong JY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
    Kaza E; Ablasser K; Poutias D; Griffiths ER; Saad FA; Hofstaetter JG; del Nido PJ; Friehs I
    Cardiovasc Res; 2011 Feb; 89(2):410-8. PubMed ID: 20935166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition.
    Liu ZH; Zhang Y; Wang X; Fan XF; Zhang Y; Li X; Gong YS; Han LP
    Biomed Pharmacother; 2019 Oct; 118():109227. PubMed ID: 31351433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
    Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
    Sharma V; Dogra N; Saikia UN; Khullar M
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
    Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
    J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone Alleviates Cardiac Fibrosis and Inhibits Endothelial to Mesenchymal Transition Induced by Pressure Overload.
    Wei WY; Zhang N; Li LL; Ma ZG; Xu M; Yuan YP; Deng W; Tang QZ
    Cell Physiol Biochem; 2018; 45(1):26-36. PubMed ID: 29310116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitriol Attenuates Doxorubicin-Induced Cardiac Dysfunction and Inhibits Endothelial-to-Mesenchymal Transition in Mice.
    Tsai TH; Lin CJ; Hang CL; Chen WY
    Cells; 2019 Aug; 8(8):. PubMed ID: 31405028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfection of hepatocyte growth factor attenuates the progression of cardiac remodeling in the hypertrophied heart.
    Iwata K; Sawa Y; Kitagawa-Sakakida S; Kawaguchi N; Matsuura N; Nakamura T; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):719-25. PubMed ID: 16153919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.
    Yan F; Zhang GH; Feng M; Zhang W; Zhang JN; Dong WQ; Zhang C; Zhang Y; Chen L; Zhang MX
    Mol Med; 2015 Feb; 21(1):15-25. PubMed ID: 25715248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
    Zhang H; Hu J; Liu L
    Biomed Pharmacother; 2017 Nov; 95():215-222. PubMed ID: 28846982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyssynchronous pacing triggers endothelial-mesenchymal transition through heterogeneity of mechanical stretch in a canine model.
    Mai J; Hu Q; Xie Y; Su S; Qiu Q; Yuan W; Yang Y; Song E; Chen Y; Wang J
    Circ J; 2015; 79(1):201-9. PubMed ID: 25373595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine Prevents Isoproterenol-Induced Cardiac Fibrosis by Regulating Endothelial-to-Mesenchymal Transition.
    Jiang XH; Wu QQ; Xiao Y; Yuan Y; Yang Z; Bian ZY; Chang W; Tang QZ
    Planta Med; 2017 Jun; 83(9):761-769. PubMed ID: 28010025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal Transition.
    Chen X; Xia X; Dong T; Lin Z; Du L; Zhou H
    Drug Des Devel Ther; 2022; 16():2517-2527. PubMed ID: 35946039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.